← Every applicant
Ph Health FDA Approvals
23 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| LEUPROLIDE ACETATENew drugJun 9, 2025SOLUTION, SUBCUTANEOUS |
| SITAGLIPTIN AND METFORMIN HYDROCHLORIDENew drugJun 4, 2025TABLET, EXTENDED RELEASE, ORAL |
| IBUPROFEN AND FAMOTIDINENew drugMar 22, 2024TABLET, ORAL |
| ADRENALINNew drugApr 21, 2023SOLUTION, INTRAVENOUS |
| BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDENew drugMar 6, 2023CAPSULE, ORAL |
| TOPIRAMATENew drugMar 1, 2023CAPSULE, EXTENDED RELEASE, ORAL |
| TIOPRONINNew drugFeb 24, 2023TABLET, DELAYED RELEASE, ORAL |
| ALVIMOPANNew drugJan 24, 2023CAPSULE, ORAL |
| DOXYCYCLINE HYCLATENew drugDec 7, 2022INJECTABLE, INJECTION |
| NALOXONE HYDROCHLORIDENew drugJul 29, 2022INJECTABLE, INJECTION |
| LUBIPROSTONENew drugJun 27, 2022CAPSULE, ORAL |
| TIOPRONINNew drugJun 2, 2022TABLET, ORAL |
| POSACONAZOLENew drugMay 25, 2022SOLUTION, INTRAVENOUS |
| TOLVAPTANNew drugFeb 15, 2022TABLET, ORAL |
| METHYLPREDNISOLONE ACETATENew drugJan 21, 2022INJECTABLE, INJECTION |
| GLYCEROL PHENYLBUTYRATENew drugDec 2, 2021LIQUID, ORAL |
| ISOSORBIDE DINITRATENew drugNov 23, 2021TABLET, ORAL |
| CALCITONIN-SALMONNew drugNov 10, 2021INJECTABLE, INJECTION |
| EVEROLIMUSNew drugOct 18, 2021TABLET, ORAL |
| COLCHICINENew drugAug 12, 2021TABLET, ORAL |
| VARENICLINE TARTRATENew drugAug 11, 2021TABLET, ORAL |
| GLYCOPYRROLATENew drugAug 9, 2021SOLUTION, ORAL |
| MICAFUNGINNew drugJun 16, 2021POWDER, INTRAVENOUS |